DiagnoCure Provides Update on Operations
QUEBEC CITY, April 1 /CNW Telbec/ - DiagnoCure Inc. today provided an
update on its Previstage(TM) GCC Colorectal Cancer Staging Test and its PCA3
test for prostate cancer. "We have recently reached some key milestones, which
represent a great start for 2008 and beyond", said John Schafer, President and
CEO of DiagnoCure.